Dolly A. Vance

2016

In 2016, Dolly A. Vance earned a total compensation of $1.1M as Executive Vice President, Corporate Affairs, General Counsel and Corporate Secretary at Rigel Pharmaceuticals, a 1% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$159,190
Option Awards$493,380
Salary$489,814
Other$1,794
Total$1,144,178

Vance received $493.4K in option awards, accounting for 43% of the total pay in 2016.

Vance also received $159.2K in non-equity incentive plan, $489.8K in salary and $1.8K in other compensation.

Rankings

In 2016, Dolly A. Vance's compensation ranked 7,580th out of 14,075 executives tracked by ExecPay. In other words, Vance earned more than 46.1% of executives.

ClassificationRankingPercentile
All
7,580
out of 14,075
46th
Division
Manufacturing
2,873
out of 5,489
48th
Major group
Chemicals And Allied Products
948
out of 1,895
50th
Industry group
Drugs
734
out of 1,538
52nd
Industry
Pharmaceutical Preparations
586
out of 1,176
50th
Source: SEC filing on March 29, 2017.

Vance's colleagues

We found four more compensation records of executives who worked with Dolly A. Vance at Rigel Pharmaceuticals in 2016.

2016

Raul Rodriguez

Rigel Pharmaceuticals

Chief Executive Officer

2016

Anne-Marie Duliege

Rigel Pharmaceuticals

Chief Medical Officer

2016

Eldon Mayer

Rigel Pharmaceuticals

Executive Vice President, Chief Commercial Officer

2016

Ryan Maynard

Rigel Pharmaceuticals

Chief Financial Officer

News

You may also like